Search Results for citation:"90 FR 13894"

SpecGx LLC has applied to the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances. The company aims to import these substances for the purpose of manufacturing Active Pharmaceutical Ingredients, which will then be distributed to its customers. However, this registration does not automatically allow for permit applications to import these substances to be approved; approval will be granted only if the business activities comply with specific legal requirements. Public comments or requests for a hearing regarding this application are open until April 28, 2025, and can be submitted electronically through the Federal eRulemaking Portal.

The Office of Personnel Management (OPM) is inviting comments from the public and federal agencies regarding the renewal of a previously expired information collection request titled "Evidence to Prove Dependency of a Child, RI 25-37." This request is used to gather information to determine whether a child of a deceased federal employee or annuitant qualifies to receive benefits. The deadline for submitting comments is May 27, 2025. The OPM is interested in feedback on the necessity, accuracy, quality, and burden of the information collection process.